Part II of Release
BIOMET, INC. -- QUARTERLY RESULTS
FOR THE PERIODS ENDED MAY 31
(in thousands, except per share data)
Three Months Ended Three Months Ended
May 31, 2000 May 31, 1999
Before Non-Recurring Reported
Non-Recurring Charges
Charges
Net Sales $250,216 $223,843 $223,843
Cost of Sales 75,126 68,500 68,500
-------- -------- --------
Gross Profit 175,090 155,343 155,343
S, G, & A 89,810 82,749 48,447 131,196
R & D 10,674 10,274 _ 10,274
-------- -------- -------- --------
Operating
Income 74,606 62,320 48,447 13,873
Other Income 5,094 4,324 4,324
-------- -------- -------- --------
Income Before Taxes
And Minority
Interest 79,700 66,644 48,447 18,197
Income Taxes 26,609 24,325 23,859 466
-------- -------- -------- --------
Income Before
Minority
Interest 53,091 42,319 24,588 17,731
Minority
Interest 2,470 670 1,918 2,588
-------- -------- -------- --------
Net Income 50,621 41,649 26,506 15,143
Earnings per Share:
Basic .29 .24 .09
Diluted .28 .23 .09
U.S. sales $163,373 $145,485
Foreign sales 86,843 78,358
Reconstructive
sales $157,501 141,868
Fixation sales 48,773 43,292
Spinal products 15,548 12,664
Other product
sales 28,394 26,019
Twelve Months Ended
May 31, 2000
Before Non-Recurring
Non-Recurring Charges Reported
Charges
Net Sales $920,582 $920,582
Cost of Sales 278,382 278,382
-------- --------
Gross Profit 642,200 642,200
S, G, & A 326,617 11,700 338,317
R & D 40,208 40,208
-------- -------- --------
Operating Income 275,375 11,700 263,675
Other Income, Net 17,017 17,017
-------- -------- --------
Income Before Taxes
and Minority Interest 292,392 11,700 280,692
Income Taxes 104,038 4,300 99,738
-------- -------- --------
Income Before
Minority Interest 188,354 7,400 180,954
Minority Interest 7,183 7,183
-------- -------- --------
Net Income 181,171 7,400 173,771
Earnings per Share:
Basic 1.03 .99
Diluted 1.02 .98
U.S. sales $609,293
Foreign sales 311,289
Reconstructive sales 580,239
Fixation sales 180,336
Spinal products 54,119
Other product sales 105,888
Twelve Months Ended
May 31, 1999
Before Non-Recurring Reported
Non-Recurring Charges
Charges
Net Sales $827,902 $827,902
Cost of Sales 259,429 259,429
-------- --------
Gross Profit 568,473 568,473
S, G, & A 295,401 48,447 343,848
R & D 38,723 38,723
-------- -------- --------
Operating Income 234,349 48,447 185,902
Other Income, Net 13,899 13,899
-------- -------- --------
Income Before Taxes
and Minority Interest 248,248 48,447 199,801
Income Taxes 91,176 23,859 67,317
-------- -------- --------
Income Before
Minority Interest 157,072 24,588 132,484
Minority Interest 5,540 1,918 7,458
-------- -------- --------
Net Income 151,532 26,506 125,026
Earnings per Share:
Basic .87 .72
Diluted .86 .71
U.S. sales 548,510
Foreign sales 279,392
Reconstructive sales 521,365
Fixation sales 162,825
Spinal products 45,125
Other product sales 98,587
--------------------------------------------------------------------------------
Contact:
Biomet, Inc.
Greg W. Sasso, 219/372-1528
Barb Goslee, 219/372-1514 |
